Bespalov, Anton

Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies

Hillen, H., Barghorn, S., Striebinger, A., Labkovsky, B., Müller, R., Nimmrich, V., Nolte, M. W., Perez-Cruz, C., van der Auwera, I., van Leuven, F., et al. (2010) · The Journal of Neuroscience

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 113

Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia

Krupitsky, E. M., Zvartau, E. E., Masalov, D. V., Tsoy, M. V., Burakov, A. M., Egorova, V. Y., Didenko, T. Y., Romanova, T. N., Ivanova, E. B., Bespalov, A. Y., et al. (2006) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 93

Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Bespalov, A., Steckler, T., Altevogt, B., Koustova, E., Skolnick, P., Deaver, D., Millan, M. J., Bastlund, J. F., Doller, D., Witkin, J., et al. (2016) · Nature Reviews Drug Discovery

Animal testing and alternativesComputational Drug Discovery Methods

Cited by 84

Improving transparency and scientific rigor in academic publishing

Prager, E. M., Chambers, K. E., Plotkin, J. L., McArthur, D. L., Bandrowski, A. E., Bansal, N., Martone, M. E., Bergstrom, H. C., Bespalov, A., & Graf, C. (2019) · Journal of Neuroscience Research

Academic Writing and PublishingAcademic Publishing and Open Access

Cited by 83

Introduction to the EQIPD quality system

Bespalov, A., Bernard, R., Gilis, A., Gerlach, B., Guillén, J., Castagné, V., Lefevre, I. A., Ducrey, F., Monk, L., Bongiovanni, S., et al. (2021) · eLife

Research Data Management PracticesAnimal testing and alternatives

Cited by 76

Be positive about negatives–recommendations for the publication of negative (or null) results

Bespalov, A., Steckler, T., & Skolnick, P. (2019) · European Neuropsychopharmacology

Academic Writing and PublishingAcademic Publishing and Open Access

Cited by 59

Drug tolerance: a known unknown in translational neuroscience

Bespalov, A., Müller, R., Relo, A.-L., & Hudzik, T. (2016) · Trends in Pharmacological Sciences

Animal testing and alternativesNeuroscience and Neuropharmacology Research

Cited by 50

AMPA receptor antagonists reverse effects of extended habit training on signaled food approach responding in rats

Bespalov, A. Y., Harich, S., Jongen-Rêlo, A.-L., van Gaalen, M. M., & Gross, G. (2007) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorMemory and Neural Mechanisms

Cited by 8